How Beneficial Cells Are Subverted To Support Cancer Growth
1/28/2011
The most common connective tissue cell in animals is the fibroblast, which plays an important role in healing wounds. But Dr. Neta Erez of Tel Aviv University's Sackler Faculty of Medicine has now demonstrated that fibroblasts can also do a body great harm, helping to "recruit" immune cells for tumor growth...
Column Calls For Focus On Reducing Cervical Cancer Deaths
1/27/2011
"We now have the medical know-how and the tools to stamp out [cervical cancer] once and for all," Cervical Cancer-Free America Director Jennifer Smith writes in an Atlanta Journal-Constitution opinion piece. She adds, "What we need now, as our country honors National Cervical Cancer Awareness Month in January, is the will among members of the public health community to make it happen...
BioSante Announces FDA Orphan Drug Designation For Its Melanoma Cancer Vaccine
1/27/2011
BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) announced the receipt of Orphan Drug designation for its Melanoma Cancer Vaccine in the treatment of stage IIb to IV melanoma, from the FDA's Office of Orphan Products Development. Melanoma is the most deadly form of skin cancer. Orphan drug designation, as granted by the U.S...
New NICE Guidance On Preventing Skin Cancer
1/26/2011
Being out in the sun can be good for you - it provides both a good source of vitamin D and the opportunity to be physically active. However, prolonged exposure can significantly increase the risk of developing skin cancer...
Texas Gov. Pushes Sonogram Law; Virginia Overturns HPV Vaccine Mandate
1/26/2011
Texas Gov. Rick Perry (R) on Saturday announced plans to give emergency designation to a bill (SB 16) that would require a woman seeking an abortion to view a sonogram, listen to the fetal heartbeat and then sign a document stating that she received the sonogram and understands the consequences of abortion, the Austin American-Statesman reports...
ArQule, Inc. (NASDAQ: ARQL) announced the presentation of Phase 1 results of a clinical trial among patients with metastatic colorectal cancer (CRC) treated with ARQ 197, a selective small molecule inhibitor of the c-MET receptor tyrosine kinase, in combination with irinotecan and cetuximab. ARQ 197 is under development by Daiichi Sankyo Co., Ltd. and ArQule...
Biomarker Test Shows Promise For Melanoma Diagnosis
1/25/2011
A new study shows that a test of biomarkers for DNA methylation is technically feasible and could aid in earlier, more precise diagnosis of melanoma...
Skin Cancer Medication Significantly Improves Survival Without Worsening Illness
1/22/2011
Late-stage trial data showed that Roche's skin cancer drug, RG7204, helps patients with BRAF V600 mutation-positive metastatic Melanoma survive for longer without their cancer progressing. The company said the Phase III clinical study met its co-primary endpoing, showing "a significant survival benefit in people with previously untreated BRAF V600 mutation-positive metastatic melanoma...
Everist Genomics, a prognostics company focused on developing gene-based molecular assays for the prediction of cancer recurrence, announced the positive results of the first external validation study of its OncoDefender-CRC colorectal cancer recurrence test...
Genomic Health, Inc...